KINDEVA DRUG DELIVERY LP

KINDEVA DRUG DELIVERY LP (United Kingdom) holds 3 active US FDA Type II Drug Master Files and is linked to 1 FDA-registered manufacturing site. 11 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “KINDEVA DRUG DELIVERY LP: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/kindeva-drug-delivery-lp

Overview

KINDEVA DRUG DELIVERY LP is an active pharmaceutical ingredient (API) supplier with 3 active FDA Type II Drug Master Files, covering CLIMARA PRO(R) ESTRADIOL/LEVONORGESTREL TRANSDERMAL DELIVERY SYSTEM; COATING AND DRYING PROCESS FOR THE SOLID MICROSTRUCTURED TRANSDERMAL SYSTEM (sMTS) FINISHED DRUG PRODUCT; ESTRADIOL TRANSDERMAL DRUG DELIVERY SYSTEM.

Core services & business areas

Pharmaceutical ManufacturingFormulationProduct DevelopmentScale-up ManufacturingCommercial ManufacturingInhalation Drug DeliveryTransdermal Drug DeliveryMicroneedle Drug Delivery

API / Drug Master Files

KINDEVA DRUG DELIVERY LP holds 3 active (3 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • COATING AND DRYING PROCESS FOR THE SOLID MICROSTRUCTURED TRANSDERMAL SYSTEM (sMTS) FINISHED DRUG PRODUCTActive2011-03-10
  • CLIMARA PRO(R) ESTRADIOL/LEVONORGESTREL TRANSDERMAL DELIVERY SYSTEMActive2000-06-16
  • ESTRADIOL TRANSDERMAL DRUG DELIVERY SYSTEMActive1992-08-31

Registered manufacturing sites (1)

Physical sites registered with the US FDA and resolved to KINDEVA DRUG DELIVERY LP, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

11 FDA enforcement records linked to this company.

  • 4832025-11-13

    Control procedures to monitor and validate performance

  • 4832025-11-13

    No written record of investigation

  • 4832019-01-25

    Procedures not in writing, fully followed

  • 4832019-01-25

    Failing drug products not rejected

  • 4832017-03-06

    Scientifically sound laboratory controls

  • 4832015-09-01

    Review of representative number of batches

  • 4832015-09-01

    Scientifically sound laboratory controls

  • 4832015-09-01

    Control procedures to monitor and validate performance

  • 4832014-09-17

    Computer control of master formula records

  • 4832010-02-12

    SOPs not followed / documented

  • 4832010-02-12

    Written procedures fail to include

For suppliers

Is this KINDEVA DRUG DELIVERY LP?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.